ArticleInternational journal of clinical and experimental medicine2014
Hybrid PET/MR imaging in two sarcoma patients - clinical benefits and implications for future trials.
Article in International journal of clinical and experimental medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Article
- Imaging update on soft tissue sarcoma.Journal of clinical orthopaedics and trauma · 2021Review
- Multimodality imaging of adult rhabdomyosarcoma: the added value of hybrid imaging.The British journal of radiology · 2020Review
- Nodal metastases of soft tissue sarcomas: risk factors, imaging findings, and implications.Skeletal radiology · 2020Review
- Applications of PET/CT and PET/MR Imaging in Primary Bone Malignancies.PET clinics · 2018Review
- Applications of PET-MRI in musculoskeletal disease.Journal of magnetic resonance imaging : JMRI · 2018Review
- Integrated 18F-FDG PET/MRI compared to MRI alone for identification of local recurrences of soft tissue sarcomas: a comparison trial.European journal of nuclear medicine and molecular imaging · 2017Article
- Combining standardized uptake value of FDG-PET and apparent diffusion coefficient of DW-MRI improves risk stratification in head and neck squamous cell carcinoma.European radiology · 2016Article
- Utility of positron emission tomography-magnetic resonance imaging in musculoskeletal imaging.World journal of radiology · 2016Review
- Diffusion-weighted imaging in musculoskeletal radiology-clinical applications and future directions.Quantitative imaging in medicine and surgery · 2015Review
- Diagnosis efficiency for pulmonary embolism using magnetic resonance imaging method: a meta-analysis.International journal of clinical and experimental medicine · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PET/MRI is an evolving hybrid imaging modality which combines the inherent strengths of MRIs soft-tissue and contrast resolution and PETs functional metabolic capabilities. Bone and soft-tissue sarcoma are a relatively rare tumor entity, relying on MRI for local staging and often on PET/CT for lymph node involvement and metastatic spread evaluation. The purpose of this article is to demonstrate the successful use of PET/MRI in two sarcoma patients. We also use these patients as a starting point to discuss how PET/MRI might be of value in sarcoma. Among its potential benefits are: superior TNM staging than either modality alone, decreased radiation dose, more sensitive and specific follow-up and better assessment of treatment response. These potentials need to be investigated in future PET/MRI soft-tissue sarcoma trials.
Indexed as
Identifiers
24753758PMC3992403What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.